Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.

Candida krusei has become an increasingly important invasive pathogen, particularly in AIDS patients and is highly resistant to fluconazole. In vitro growth inhibition studies revealed that fluconazole and ketoconazole were approximately 800- and 19-fold less inhibitory than itraconazole. The inhibition and interaction of itraconazole, fluconazole and ketoconazole with the sterol 14 alpha-demethylase of C. krusei was studied using in vitro ergosterol biosynthesis and difference spectroscopy, respectively. Both itraconazole and ketoconazole inhibited in vitro ergosterol biosynthesis at lower concentrations than fluconazole. All three drugs interacted with microsomal P450 and interfered in the binding of carbon monoxide to P450 in direct proportion to their inhibitory effect on ergosterol biosynthesis in cell-free extracts. The slightly lower affinity of sterol 14 alpha-demethylase for fluconazole compared with itraconazole and ketoconazole is only partially responsible for poor activity of fluconazole on C. krusei.

[1]  S. Kelly,et al.  Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays , 1996, Antimicrobial agents and chemotherapy.

[2]  S. Kelly,et al.  Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. , 1995, FEMS microbiology letters.

[3]  D. Denning,et al.  In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp , 1995, Antimicrobial agents and chemotherapy.

[4]  P. Marichal,et al.  Origin of differences in susceptibility of Candida krusei to azole antifungal agents , 1995, Mycoses.

[5]  J. Sobel,et al.  Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[6]  J. Wingard.  Changes in the Spectrum of Fungal Infections in Bone Marrow Transplant Patients , 1994 .

[7]  B. Dupont.  Invasive Fungal Infections Caused by Yeasts as Emerging Pathogens , 1994 .

[8]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[9]  D. Kelly,et al.  Molecular studies on azole sensitivity in fungi , 1993 .

[10]  J. Kapteyn,et al.  Isolation of microsomal cytochrome-P450 isozymes from Ustilago maydis and their interaction with sterol demethylation inhibitors. , 1992 .

[11]  A. Kerkenaar,et al.  Interaction of microsomal cytochrome P450 isozymes isolated from Penicillium italicum with DMI fungicides. , 1992 .

[12]  R. Hay.  Overview of the treatment of disseminated fungal infections. , 1991, The Journal of antimicrobial chemotherapy.

[13]  G. Dettori,et al.  In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. , 1991, Chemotherapy.

[14]  S. Kelly,et al.  Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. , 1990, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[15]  David John Adams,et al.  Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. , 1990, The Biochemical journal.

[16]  H. Geerts,et al.  Mode of Action Studies: Basis for the Search of New Antifungal Drugs , 1988, Annals of the New York Academy of Sciences.

[17]  H. Geerts,et al.  The Molecular Basis for Itraconazole’s Activity against Aspergillus Fumigatus , 1988 .

[18]  Y. Yoshida.  Cytochrome P450 of fungi: primary target for azole antifungal agents. , 1988, Current topics in medical mycology.

[19]  Patrick Marichal,et al.  Interaction of azole derivatives with cytochrome P‐450 isozymes in yeast, fungi, plants and mammalian cells , 1987 .

[20]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.